Restamin

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Restamin

Property Description
Active ingredient Diphenhydramine hydrochloride
Form Oral (tablet, syrup, capsule), Injection, Topical Cream
Pharmacological class First-generation Antihistamine
Common purpose Allergic relief, Sedation, Motion sickness
Origin Synthetic compound (Ethanolamine derivative)

Restamin is a pharmaceutical product containing the active substance Diphenhydramine (specifically Diphenhydramine hydrochloride), which is classified as a first-generation antihistamine. This medication is fundamentally defined by its chemical composition as a synthetic compound derived from Ethanolamine, utilized broadly for its histamine-blocking and marked sedative properties. It is consistently formulated as a single active ingredient product, positioning it distinctively from preparations that combine it with decongestants or analgesics. The identity of Restamin establishes it as an agent targeting the physiological effects of histamine, and it is utilized for its efficacy across multiple therapeutic uses. Diphenhydramine is recognized for both its utility in managing allergic symptoms and its prominent sedative properties.


Defining Restamin: Active Ingredient and Pharmacological Class

The core component of Restamin is Diphenhydramine hydrochloride (C17H21NO). This compound is classified as a Histamine H1 receptor antagonist, meaning its primary mechanism is to competitively block the effects of histamine released by the body during allergic responses. This classification is vital, as first-generation agents are known for their ability to cross the blood-brain barrier readily, resulting in the Central Nervous System (CNS) depression that newer antihistamines often minimize. This characteristic dual function provides a specific benefit for users seeking temporary relief from symptoms like allergic rhinitis combined with the need for rest. First-generation antihistamines like this are defined by their capacity to induce drowsiness as a consequence of their central action.

Forms, Types, and General Purpose

Restamin is supplied in multiple dosage forms, including common oral forms such as tablets, capsules, and syrup, as well as parenteral preparations for injection and topical cream formulations. These varied forms allow for both systemic and topical administration to achieve the desired effect. The general purpose of Restamin is rooted in leveraging its H1 receptor blockade to broadly relieve the discomfort associated with allergic conditions, such as itching and sneezing. Furthermore, the inherent sedative effect makes the drug generally useful for managing occasional sleeplessness and controlling the symptoms related to motion sickness through its secondary anticholinergic action. This versatility in addressing different patient needs based on the same mechanism underscores the utility of this specific first-generation agent.

What side effects are possible with Restamin?

Possible Side Effects and Safety Information

The safety profile of Restamin (Diphenhydramine) is formally defined by effects predominantly related to the central nervous system and anticholinergic activity, as documented in regulatory sources.

Official Adverse Reactions

The most frequently documented adverse reactions, classified as Common in official labeling, include sedation (drowsiness, somnolence), dry mouth, dizziness, and fatigue. Reactions affecting other systems are also noted:

  • Nervous System Disorders: Disturbance in attention, unsteadiness, headache.
  • Gastrointestinal Disorders: Constipation, nausea, vomiting, epigastric distress.
  • Eye and Urinary Disorders: Blurred vision and urinary retention are documented anticholinergic effects.

Serious and Population-Specific Safety Notes

While rare, regulatory documents note the possibility of serious adverse reactions, including convulsions and severe hypersensitivity reactions (such as anaphylactic shock or blood dyscrasias).

Specific safety considerations are defined for certain populations:

  • Older Adults: This group may be more susceptible to anticholinergic effects (e.g., confusion, urinary retention) and low blood pressure (hypotension).
  • Children: Pediatric patients may experience a paradoxical excitation effect, manifesting as increased restlessness or agitation, instead of sedation.

Adverse effects, particularly sedation and dry mouth, are often most prominent following the initial doses of treatment. Regulatory constraints advise caution or contraindicate use in patients with pre-existing conditions such as narrow-angle glaucoma and symptomatic prostatic hypertrophy.

Overdose and Emergency Response

Overdose and When to Seek Help

Regulatory documents specify that overdose with Restamin (Diphenhydramine) presents a serious risk, requiring immediate professional assessment. The manifestations involve a dual effect on the Central Nervous System (CNS), progressing from extreme drowsiness, confusion, and disorientation to states of CNS excitation, restlessness, hallucinations, delirium, and seizures. Additional documented signs include severe anticholinergic effects such as dilated pupils, dry mouth, flushing, and urinary retention, alongside cardiovascular effects like tachycardia and hypotension.

Severe outcomes officially documented by regulatory authorities include life-threatening complications such as coma, respiratory depression, serious cardiac arrhythmias, and the potential for death. Pediatric patients are noted to be particularly susceptible to CNS excitation and seizures in overdose, while elderly individuals are more prone to profound sedation and hypotension.

Official instructions mandate that individuals seek immediate medical attention and contact poison control. Urgent professional care is required if the person is hallucinating, cannot be awakened, has a seizure, has trouble breathing, or has collapsed. Management, as described in regulatory labels, is supportive and symptomatic since no specific antidote is known. It typically requires monitoring of vital signs, including the electrocardiogram (ECG), due to the documented risk of cardiac toxicity.

Therapeutic Uses of Restamin

Restamin (Diphenhydramine) provides short-term symptomatic assistance across several distinct therapeutic domains, generally offering supportive relief for conditions where symptoms create noticeable physiological strain and discomfort.

This medication is commonly used to help with a range of acute symptoms. It is applicable within clinical settings that involve acute or disruptive symptom patterns, and plays a role in managing symptoms related to: hay fever (allergic rhinitis), acute hives (urticaria), occasional sleeplessness, and motion sickness. The medication may also be part of symptomatic management for drug-induced involuntary movements (dystonia) and is used as an adjunctive agent for severe allergic episodes.

The goal of symptomatic relief is to help manage distressing manifestations. This offers symptomatic relief that may assist with managing symptoms that create noticeable physiological strain.


Benefit Focus: Relief for Episodic Distress

Restamin is commonly used when short-term symptomatic assistance is needed to address symptom clusters that may become intense or disruptive, such as widespread itching, frequent sneezing, and nausea associated with travel. This offers symptomatic relief that supports patients during episodes of heightened discomfort.

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Who Can and Cannot Use Restamin?

This section defines the official eligibility rules for Restamin (Diphenhydramine) based strictly on governmental regulatory documentation.


Eligibility Status by Population

Restamin is contraindicated (must not be used) in several specific patient groups due to the high risk of adverse effects, as specified in regulatory labeling.

Status Population/Condition
Contraindicated Neonates and Premature Infants
Contraindicated Nursing/Breastfeeding Mothers
Contraindicated Known Hypersensitivity to the drug or similar antihistamines
Contraindicated Concurrent use of other diphenhydramine products

Conditional Use and Restrictions

Use is restricted or requires considerable caution in other specific populations:

  • Elderly Patients (Geriatrics) are more susceptible to effects like sedation and dizziness, mandating caution.
  • Patients with severe renal or hepatic impairment may require conditional use due to potential drug accumulation.
  • Individuals with conditions sensitive to anticholinergic effects, such as narrow-angle glaucoma or symptomatic prostatic hypertrophy, must use Restamin with caution.
  • The drug is not recommended for children under 2 years of age for OTC purposes. Use during pregnancy (FDA Category B) is conditional, generally requiring that the benefit outweighs the potential risk.

What should I know about interactions with other medicines?

Official Regulatory Information for Restamin Interactions

The interaction profile for Restamin (Diphenhydramine) is primarily defined by the potential for additive pharmacological effects, as documented in official regulatory labeling. These interactions are categorized based on their ability to reinforce the drug's inherent properties, specifically Central Nervous System (CNS) depression and anticholinergic effects.

Contraindicated and Significant Pharmacodynamic Interactions

Interacting Agent Category Documented Interaction Outcome Restriction Type
Monoamine Oxidase Inhibitors (MAOIs) Contraindicated, as MAOIs are documented to prolong and intensify the anticholinergic effects. Contraindicated Combination
CNS Depressants (Alcohol, Sedatives, Opioids) Exhibits additive effects on the Central Nervous System. Clinically Significant
Other Anticholinergic Drugs Co-administration may intensify or worsen anticholinergic effects. Clinically Significant

Co-use with alcohol is restricted due to these documented additive effects on the CNS. In pharmacokinetics studies involving co-administration, it was documented that a substance such as Naproxen did not change the Area Under the Curve (AUC) or maximum plasma concentration ( C max) of Diphenhydramine, but did increase the time to maximum concentration ( T max).

Population-Specific Considerations

The regulatory label notes that elderly patients, defined as approximately 60 years or older, are more likely to experience specific side effects like dizziness or sedation when combining the medication with CNS depressants. Furthermore, use in neonates or premature infants is formally documented as a contraindicated restriction.

Mechanism of Action

How Restamin Works: Mechanism of Action

Restamin's primary action involves a multi-target pharmacodynamic profile. It functions as an inverse agonist at peripheral histamine H1 receptors ( H1 R), thereby antagonizing the activity of released histamine. This mechanism limits the downstream signaling of the acute histamine cascade, which contributes to a decrease in vascular permeability and fluid exudation.

Due to its lipophilicity, Restamin readily crosses the blood-brain barrier to target central H1 R on neurons critical for regulating wakefulness. Antagonism in these histaminergic arousal pathways leads directly to the physiological consequence of central nervous system (CNS) depression.

Secondary actions include functioning as an antagonist at muscarinic acetylcholine receptors and inhibiting certain voltage-gated sodium channels. This multi-target interaction affects both neural and parasympathetic functions. The physiological consequences include a decrease in glandular secretions and altered signal transduction in pathways governing motion-related input.

Dosage and Administration Information

How to Use Restamin (Diphenhydramine): Administration Guidelines

The usage of Restamin, which contains Diphenhydramine, is governed by specific instructions focusing on administration route, dosage limits, and timing. The medication is available for Oral (PO), Intramuscular (IM), Intravenous (IV), and Topical routes, allowing for both systemic and local application.


Official Dosing and Frequency

Administration Type Standard Adult Dose Maximum Daily Dose Frequency Pattern
Oral (Allergy/Symptoms) 25 mg to 50 mg 300 mg Every 4 to 6 hours, as needed
Oral (Sleep-Aid) 50 mg 300 mg Once daily, 20-30 minutes before bedtime
Parenteral (IM/IV) 10 mg to 50 mg (up to 100 mg if necessary) 400 mg Every 4 to 6 hours, as needed

Administration and Procedural Rules

Oral forms may be taken with or without food. For liquid forms, an accurate dosing device must be used for measurement.

Special Conditions: The injectable solution must be administered via deep IM injection or as a slow IV infusion, with the intravenous rate generally not exceeding 25 mg per minute. Guidelines suggest administering a lower initial dose for older adults due to altered clearance patterns. The medicine is intended for short-term use; for example, its use as a sleep aid should generally not be continuous for longer than two weeks.

Recent Clinical Evidence

Restamin (active ingredient: diphenhydramine) is a first-generation antihistamine that has been the subject of numerous studies investigating its use in allergic conditions, sleep, and certain types of pain management.

Core Research Areas

Clinical evidence primarily focuses on the medication's effects related to its antihistaminic and sedative properties. The table below summarizes key findings from clinical trials and reviews:

Research Area Key Study Findings Note on Evidence
Allergic Symptoms Studies consistently show use is associated with a reduction in symptoms like sneezing, runny nose, and itching related to seasonal allergies and hives. Strong evidence supporting reduction of acute allergic symptoms.
Short-Term Insomnia Research suggests its use may be associated with improved sleep onset and duration in adults with temporary sleep difficulty. Evidence supports short-term use; tolerance may develop rapidly.
Pain Management Some studies have explored whether diphenhydramine, when used alongside other medications, is associated with differences in acute pain relief, particularly in emergency settings. Evidence remains limited, often involving specialized populations (e.g., specific headaches or post-operative pain).

Safety and Special Populations

  • Cognitive Function: Observational studies have explored an association between the cumulative use of strong anticholinergic medications (including first-generation antihistamines like Restamin) and an increased risk of dementia over time. Further research is necessary to clarify this relationship.
  • Elderly Patients: Due to the risk of increased side effects, including sedation, dizziness, and confusion, first-generation antihistamines are often listed as potentially inappropriate for older adults in some guidelines (e.g., the Beers Criteria).
  • Sedation: Due to its central nervous system effects, clinical trials consistently cite drowsiness as a common adverse event. This finding impacts patient guidance related to operating machinery or driving.

Frequently Asked Questions (FAQ)

Common questions about Restamin (FAQ)


Q: How long does one dose of Restamin typically last in the body?

Official product information describes the pharmacokinetics of the drug, which is how the body processes it. The time it takes for half of the medication to be eliminated from the body, known as the half-life, is typically only a few hours in adults. This duration is why the medication may be administered every four to six hours to maintain its effect.


Q: What are the known long-term safety themes for Restamin?

Long-term safety notes indicate that the body may develop tolerance to the effects of the drug over time. Additionally, studies have explored an association between cumulative, long-term use of this class of strong anticholinergic medications and an increased risk of cognitive issues. These safety themes inform the official guidance, which emphasizes short-term use.


Q: Can Restamin change the results of certain lab tests?

According to official patient information, the medication may interfere with the results of certain allergy skin tests. Regulatory information notes that temporary discontinuation of the medication may be necessary prior to such testing. This precaution is necessary to ensure the accuracy of the test results.


Q: What is the general expectation for how long Restamin is typically used?

Restamin is generally described in official documents as a medication intended for short-term use in managing symptoms. For its use as a temporary sleep aid, official guidelines advise against using it continuously for longer than two weeks. The duration of use is typically described in relation to the presence of the temporary symptoms being treated.


Q: Is Restamin the same as other similar sounding over-the-counter medicines?

The active ingredient in Restamin is Diphenhydramine, which is the official generic component. Because of this, Diphenhydramine is also found as the main ingredient in many other branded and generic over-the-counter products marketed for similar uses. This is why the product name may differ even when the core medication is the same.


Q: Are there any specific supplements that interact with Restamin?

Official interaction resources have noted a potential for additive effects when Restamin is co-administered with certain herbal supplements, such as St. John’s Wort. Combining these products may intensify side effects like sedation and drowsiness.


Q: Is it safe to take Restamin with common cold and flu remedies?

Combining Restamin with cold and flu remedies is addressed by interaction warnings concerning Central Nervous System (CNS) effects. If cold remedies contain other ingredients that cause drowsiness, such as dextromethorphan or doxylamine, combining them may lead to a greater increase in side effects like dizziness or confusion.


Q: Is there a generic version of Restamin available?

Yes, the active ingredient in Restamin is Diphenhydramine hydrochloride. This compound is the generic form of the drug and is widely available in generic formulations supplied by numerous manufacturers.


Q: How long has Restamin been on the market?

Historical regulatory records indicate that the active ingredient, Diphenhydramine, was first approved by the U.S. Food and Drug Administration (FDA) in 1946. This classification makes it one of the earliest and most established antihistamines available.


Q: Why do some people say Restamin didn't work for them?

Individual patient responses to any medication can vary widely due to many factors. Furthermore, research evidence indicates that tolerance, which is a reduced response to the drug over time, may develop rapidly for the sedative effects of the medication.


Q: Does Restamin affect my mood?

Safety documentation notes that changes in thinking and behavior, as well as disturbances in attention, have been reported with this class of sedating medications. In pediatric patients, there is also the risk of a paradoxical effect, which can manifest as increased restlessness or agitation instead of drowsiness.


Q: Is it possible to become dependent on Restamin?

The active ingredient is not classified as a controlled substance by the DEA. However, authoritative medical literature has documented instances of misuse and abuse, and a withdrawal syndrome has been reported following abrupt cessation after chronic, high-dose use.


Q: What happens if I forget to take Restamin?

Official patient guidance describes that the recommended step for a missed dose is to take it as soon as it is remembered. However, if it is almost time for the next scheduled dose, the guidance describes taking only that next dose. The guidance also notes that taking double or extra doses to compensate for a missed dose is not advised.


Q: Is Restamin covered by most insurance plans?

While coverage is determined by individual health plans, the active ingredient in Restamin is widely available in low-cost generic form. Due to its status, it is typically included in major government prescription drug coverage plans, such as Medicare Part D, and many private insurance formularies.


Q: Why is Restamin sometimes prescribed for a different use than its main purpose?

Government regulations allow licensed physicians the discretion to prescribe an FDA-approved drug for indications that are not specifically listed on the official product labeling. This practice, known as off-label prescribing, is a standard component of medical practice, though it is not part of the manufacturer’s approved claims.


Q: Does Restamin have a cumulative effect over time?

While the intended effects of a single dose are temporary, research suggests there may be a potential cumulative effect over time. This is related to the drug's strong anticholinergic properties, and the need for caution regarding cognitive function has been noted in long-term observational studies.


Q: Is Restamin available without a prescription in some countries?

Regulatory classification in the United States indicates that Restamin is an Over-the-Counter (OTC) medication for several of its intended uses. This includes temporary relief of common allergic symptoms and managing occasional sleeplessness.


Q: Does Restamin affect how well birth control works?

Based on current information found in authoritative drug interaction databases, there is no known interaction indicated between the active ingredient in Restamin and common hormonal birth control medications. This suggests that Restamin does not typically affect the effectiveness of these contraceptives.


Q: Are there any dietary restrictions while using Restamin?

Official regulatory documents and patient information highlight the co-use of the medication with alcohol as a key restriction. Alcohol consumption is restricted because of its potential to significantly increase the medication’s side effects, particularly drowsiness and Central Nervous System (CNS) depression. No other specific dietary restrictions are commonly noted.


Q: Is Restamin considered a controlled substance?

The active ingredient, Diphenhydramine, is not classified as a controlled substance under the U.S. Controlled Substances Act. However, if the active ingredient is combined with other substances that are regulated, the resulting combination product may be classified as a controlled substance.


Q: Is it necessary to finish the entire prescription of Restamin?

Unlike treatments for bacterial infections, the need to complete the entire prescription of Restamin is determined by the duration of the symptoms being managed. Since the medication is generally intended for short-term relief, use is generally described as being appropriate only while the temporary symptoms persist.


Q: Can Restamin be split in half?

The ability to safely split a tablet is dependent on the specific formulation and whether the manufacturer designed it with a score line. Official administration information directs patients to rely on the product information for their specific dosage form to determine if splitting is appropriate.


Q: Why is Restamin not recommended for children under a certain age?

Regulatory restrictions on the use of Restamin for younger children are based on documented safety concerns in that population. Specifically, official safety notes cite the risk of serious side effects, including the potential for a paradoxical excitation effect, which causes increased restlessness and agitation.

How should Restamin be stored and disposed of?

How to Store and Dispose of Restamin (Diphenhydramine)

Restamin must be stored under specific conditions to maintain stability and prevent accidental poisoning, according to regulatory guidelines.

Storage Requirements

Condition Requirement
Temperature Store at controlled room temperature (generally 20 C to 25 C).
Protection Keep away from excess heat and moisture. Do not store the product in the bathroom.
Container Keep in the original container and ensure the cap is tightly closed.
Child Safety Store out of the sight and reach of children in a secured location.

Disposal Instructions

Unused or expired Restamin should be disposed of using a local drug take-back program as the preferred method. If a take-back option is unavailable, the medication may be disposed of in household trash after being mixed with an undesirable substance (e.g., dirt or coffee grounds) and sealed in a container. Regulatory documents prohibit flushing this product down the toilet or pouring it down the sink.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Restamin found in:

A-Z Index: